Hypertension and Renal Cell Carcinoma
DOI:
https://doi.org/10.56981/Keywords:
Hypertension, Cardio-oncology Renal cell carcinomaAbstract
Advances in tumour diagnosis and treatment, particularly targeted drugs, have considerably improved renal cell carcinoma (RCC) survival while increasing the incidence of hypertension (HTN). As a result, identifying risk factors and enhancing therapeutic treatment for RCC and HTN patients are critical challenges. This study looked at both preclinical and clinical risk factors for HTN-RCC comorbidity. Obesity, smoking, and other lifestyle choices may be risk factors for both RCC and HTN. Second, RCC and HTN medications can interact with one another. Then, HTN treatment and RCC comorbidity reduction were addressed. Additionally discussed current study flaws and potential directions Finally, the goal of this study is to expand cardio-oncology knowledge and to help patients who are at high risk of or suffering from RCC and HTN.
References
1. Kuroda N, Sugawara E, Kusano H, Yuba Y, Yorita K, Takeuchi KJPJoP. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects. 2018;69(2):109-13.
2. Siegel RL, Miller KD, Jemal AJCacjfc. Cancer statistics, 2019. 2019;69(1):7-34.
3. Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow W-H, et al. Obesity and renal cell carcinoma risk by histologic subtype: a nested case-control study and meta-analysis. 2018;56:31-7.
4. Chow W-H, Dong LM, Devesa SSJNRU. Epidemiology and risk factors for kidney cancer. 2010;7(5):245-57.
5. Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, et al. The relationship between blood pressure and risk of renal cell carcinoma. 2022.
6. Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, et al. The influence of obesity-related factors in the etiology of renal cell carcinoma—a mendelian randomization study. 2019;16(1):e1002724.
7. Carey RM, Muntner P, Bosworth HB, Whelton PKJJotACoC. Prevention and control of hypertension: JACC health promotion series. 2018;72(11):1278-93.
8. Washio M, Mori M, Mikami K, Miki T, Watanabe Y, Nakao M, et al. Cigarette smoking and other risk factors for kidney cancer death in a Japanese population: Japan Collaborative Cohort Study for evaluation of cancer risk (JACC study). 2013;14(11):6523-8.
9. Kabaria R, Klaassen Z, Terris MKJIjon, disease r. Renal cell carcinoma: links and risks. 2016;9:45.
10. Liu X, Sun Q, Hou H, Zhu K, Wang Q, Liu H, et al. The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline. 2018;97(44).
11. Beebe-Dimmer JL, Colt JS, Ruterbusch JJ, Keele GR, Purdue MP, Wacholder S, et al. Body mass index and renal cell cancer: the influence of race and sex. 2012;23(6):821.
12. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case‐control studies. 2013;132(11):2640-7.
13. Sun L, Chao F, Luo B, Ye D, Zhao J, Zhang Q, et al. Impact of estrogen on the relationship between obesity and renal cell carcinoma risk in women. 2018;34:108-12.
14. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. 2014;141(2):125-39.
15. da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JEJCJoC. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. 2020;36(5):671-82.
16. Kotsis V, Nilsson P, Grassi G, Mancia G, Redon J, Luft F, et al. New developments in the pathogenesis of obesity-induced hypertension. 2015;33(8):1499-508.
17. Williams PTJM, sports si, exercise. Reduced risk of incident kidney cancer from walking and running. 2014;46(2):312.
18. Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez DS, Ntzani EE, et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. 2019;9(1):1-12.
19. Kim CS, Han K-D, Choi HS, Bae EH, Ma SK, Kim SWJH. Association of hypertension and blood pressure with kidney cancer risk: a nationwide population-based cohort study. 2020;75(6):1439-46.
20. Leiba A, Kark JD, Afek A, Derazne E, Keinan-Boker L, Shamiss A, et al. Hypertension in adolescence is not an independent risk factor for renal cancer: a cohort study of 918,965 males. 2013;7(4):283-8.
21. Ba Z, Xiao Y, He M, Liu D, Wang H, Liang H, et al. Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension. 2022;9:810262.
22. Koene RJ, Prizment AE, Blaes A, Konety SHJC. Shared risk factors in cardiovascular disease and cancer. 2016;133(11):1104-14.
23. Copland E, Canoy D, Nazarzadeh M, Bidel Z, Ramakrishnan R, Woodward M, et al. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. 2021;22(4):558-70.
24. Xie Y, Xu P, Wang M, Zheng Y, Tian T, Yang S, et al. Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis. 2020;12(2):1545.
25. Battistoni A, Volpe MJECR. Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? 2020;15.
26. Colt JS, Hofmann JN, Schwartz K, Chow W-H, Graubard BI, Davis F, et al. Antihypertensive medication use and risk of renal cell carcinoma. 2017;28(4):289-97.
27. D'Aniello C, Berretta M, Cavaliere C, Rossetti S, Facchini BA, Iovane G, et al. Biomarkers of prognosis and efficacy of anti-angiogenic therapy in metastatic clear cell renal cancer. 2019;9:1400.
28. Kim S-A, Moon H, Roh J-L, Kim S-B, Choi S-H, Nam S, et al. Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: An observational study of 10,414 person–years of follow-up. 2017;19(7):826-33.
29. Ahmed U, Chatterjee T, Kandula MJJoCHIMP. Polyarteritis Nodosa: an unusual case of paraneoplastic process in renal cell carcinoma. 2020;10(1):73-5.
30. Ogunmola OJ, Onyema C, Bakare TIB, Olabinri EO, Bamigboye-Taiwo OT, Adaje AO, et al. A 10-year old girl with resistant hypertension without significant indication of an underlying renal cell carcinoma, misdiagnosed as malaria. 2019;20:1434.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 https://creativecommons.org/licenses/by/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
